• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过颗粒扩散和肽渗透阐明肠道黏液的空间位阻和相互作用屏障特性。

Steric and interactive barrier properties of intestinal mucus elucidated by particle diffusion and peptide permeation.

作者信息

Boegh Marie, García-Díaz María, Müllertz Anette, Nielsen Hanne Mørck

机构信息

Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen O, Denmark.

Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen O, Denmark.

出版信息

Eur J Pharm Biopharm. 2015 Sep;95(Pt A):136-43. doi: 10.1016/j.ejpb.2015.01.014. Epub 2015 Jan 23.

DOI:10.1016/j.ejpb.2015.01.014
PMID:25622791
Abstract

The mucus lining of the gastrointestinal tract epithelium is recognized as a barrier to efficient oral drug delivery. Recently, a new in vitro model for assessment of drug permeation across intestinal mucosa was established by applying a biosimilar mucus matrix to the surface of Caco-2 cell monolayers. The aim of the present study was to gain more insight into the steric and interactive barrier properties of intestinal mucus by studying the permeation of peptides and model compounds across the biosimilar mucus as well as across porcine intestinal mucus (PIM). As PIM disrupted the Caco-2 cell monolayers, a cell-free mucus barrier model was implemented in the studies. Both the biosimilar mucus and the PIM reduced the permeation of the selected peptide drugs to varying degrees illustrating the interactive properties of both mucus matrices. The reduction in peptide permeation was decreased depending on the cationicity and H-bonding capacity of the permeant clearly demonstrated by using the biosimilar mucus, whereas the larger inter sample variation of the PIM matrix obstructed similarly clear conclusions. Thus, for mechanistic studies of permeation across mucus and mucosa the biosimilar mucus offers a relevant and reproducible alternative to native mucus.

摘要

胃肠道上皮的黏液层被认为是高效口服给药的一个屏障。最近,通过将生物相似性黏液基质应用于Caco-2细胞单层表面,建立了一种用于评估药物跨肠黏膜渗透的新体外模型。本研究的目的是通过研究肽和模型化合物在生物相似性黏液以及猪肠黏液(PIM)中的渗透情况,更深入地了解肠黏液的空间位阻和相互作用屏障特性。由于PIM会破坏Caco-2细胞单层,因此在研究中采用了无细胞黏液屏障模型。生物相似性黏液和PIM均不同程度地降低了所选肽类药物的渗透,这说明了两种黏液基质的相互作用特性。通过使用生物相似性黏液清楚地表明,肽渗透的降低程度取决于渗透物的阳离子性和氢键结合能力,而PIM基质较大的样本间差异阻碍了得出同样明确的结论。因此,对于跨黏液和黏膜渗透的机制研究,生物相似性黏液为天然黏液提供了一种相关且可重复的替代物。

相似文献

1
Steric and interactive barrier properties of intestinal mucus elucidated by particle diffusion and peptide permeation.通过颗粒扩散和肽渗透阐明肠道黏液的空间位阻和相互作用屏障特性。
Eur J Pharm Biopharm. 2015 Sep;95(Pt A):136-43. doi: 10.1016/j.ejpb.2015.01.014. Epub 2015 Jan 23.
2
Property profiling of biosimilar mucus in a novel mucus-containing in vitro model for assessment of intestinal drug absorption.在一种新型含黏液体外模型中对生物类似物黏液进行性质分析以评估肠道药物吸收
Eur J Pharm Biopharm. 2014 Jul;87(2):227-35. doi: 10.1016/j.ejpb.2014.01.001. Epub 2014 Jan 8.
3
Evaluation of drug permeation under fed state conditions using mucus-covered Caco-2 cell epithelium.在进食状态条件下使用覆盖黏液的 Caco-2 细胞上皮评估药物渗透。
Eur J Pharm Sci. 2018 Jun 15;118:144-153. doi: 10.1016/j.ejps.2018.02.032. Epub 2018 Mar 7.
4
Physical and barrier changes in gastrointestinal mucus induced by the permeation enhancer sodium 8-[(2-hydroxybenzoyl)amino]octanoate (SNAC).渗透促进剂 8-[(2-羟基苯甲酰基)氨基]辛酸钠(SNAC)引起的胃肠道黏液的物理和屏障变化。
J Control Release. 2022 Dec;352:163-178. doi: 10.1016/j.jconrel.2022.09.034. Epub 2022 Oct 19.
5
Development of an advanced intestinal in vitro triple culture permeability model to study transport of nanoparticles.开发一种先进的肠道体外三重培养通透性模型以研究纳米颗粒的转运。
Mol Pharm. 2014 Mar 3;11(3):808-18. doi: 10.1021/mp400507g. Epub 2014 Feb 6.
6
Facilitated nanoscale delivery of insulin across intestinal membrane models.促进胰岛素跨肠黏膜模型的纳米级递药。
Int J Pharm. 2011 Jun 30;412(1-2):123-31. doi: 10.1016/j.ijpharm.2011.04.003. Epub 2011 Apr 8.
7
Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.通过聚乙二醇化固体脂质纳米粒改善胃肠道的转运和吸收。
Mol Pharm. 2013 May 6;10(5):1865-73. doi: 10.1021/mp300649z. Epub 2013 Apr 5.
8
Mucus-penetrating nanoparticles: Promising drug delivery systems for the photodynamic therapy of intestinal cancer.黏液穿透纳米颗粒:用于肠道癌症光动力疗法的有前途的药物递送系统。
Eur J Pharm Biopharm. 2018 Aug;129:1-9. doi: 10.1016/j.ejpb.2018.05.018. Epub 2018 May 17.
9
Protease-functionalized mucus penetrating microparticles: In-vivo evidence for their potential.蛋白酶功能化黏液穿透微粒:体内证据表明其具有潜力。
Int J Pharm. 2017 Oct 30;532(1):177-184. doi: 10.1016/j.ijpharm.2017.08.114. Epub 2017 Aug 31.
10
Development and in vitro evaluation of zeta potential changing self-emulsifying drug delivery systems for enhanced mucus permeation.发展和体外评价zeta 电位变化自乳化药物传递系统,以增强黏液渗透。
Int J Pharm. 2016 Aug 20;510(1):255-62. doi: 10.1016/j.ijpharm.2016.06.045. Epub 2016 Jun 18.

引用本文的文献

1
Design and Applications of Polymersomes for Oral Drug Administration.用于口服给药的聚合物囊泡的设计与应用
ACS Appl Mater Interfaces. 2025 May 28;17(21):30423-30435. doi: 10.1021/acsami.5c04658. Epub 2025 May 15.
2
A Comprehensive Review of Challenges in Oral Drug Delivery Systems and Recent Advancements in Innovative Design Strategies.口服给药系统中的挑战及创新设计策略的最新进展综述
Curr Pharm Des. 2025;31(5):360-376. doi: 10.2174/0113816128338560240923073357.
3
"Enhancing Oral Drug Absorption: Overcoming Physiological and Pharmaceutical Barriers for Improved Bioavailability".
"增强口服药物吸收:克服生理和药物障碍以提高生物利用度"。
AAPS PharmSciTech. 2024 Oct 1;25(7):228. doi: 10.1208/s12249-024-02940-5.
4
Bioaccessibility and Antioxidant Activity of Faba Bean Peptides in Comparison to those of Pea and Soy after In Vitro Gastrointestinal Digestion and Transepithelial Transport across Caco-2 and HT29-MTX-E12 Cells.蚕豆肽的生物可给性和抗氧化活性与豌豆和大豆肽在体外胃肠道消化和 Caco-2 和 HT29-MTX-E12 细胞跨上皮转运后的比较。
J Agric Food Chem. 2024 Aug 14;72(32):17953-17963. doi: 10.1021/acs.jafc.4c02948. Epub 2024 Aug 1.
5
Gastrointestinal Permeation Enhancers Beyond Sodium Caprate and SNAC - What is Coming Next?超越癸酸钠和 SNAC 的胃肠道渗透增强剂 - 接下来会有什么?
Adv Sci (Weinh). 2024 Sep;11(33):e2400843. doi: 10.1002/advs.202400843. Epub 2024 Jun 17.
6
A Window for Enhanced Oral Delivery of Therapeutics via Lipid Nanoparticles.脂质纳米粒增强经口递药的窗口。
Drug Des Devel Ther. 2024 Feb 29;18:613-630. doi: 10.2147/DDDT.S439975. eCollection 2024.
7
Advances in the Evaluation of Gastrointestinal Absorption Considering the Mucus Layer.考虑黏液层的胃肠道吸收评估进展
Pharmaceutics. 2023 Nov 30;15(12):2714. doi: 10.3390/pharmaceutics15122714.
8
Caco-2 Cell Sheet Partially Laminated with HT29-MTX Cells as a Novel In Vitro Model of Gut Epithelium Drug Permeability.以部分层叠有HT29-MTX细胞的Caco-2细胞片作为肠道上皮药物渗透性的新型体外模型
Pharmaceutics. 2023 Sep 18;15(9):2338. doi: 10.3390/pharmaceutics15092338.
9
Advances in Oral Drug Delivery Systems: Challenges and Opportunities.口服给药系统的进展:挑战与机遇
Pharmaceutics. 2023 Feb 1;15(2):484. doi: 10.3390/pharmaceutics15020484.
10
Optimisation of a High-Throughput Model for Mucus Permeation and Nanoparticle Discrimination Using Biosimilar Mucus.使用生物类似物黏液优化用于黏液渗透和纳米颗粒区分的高通量模型
Pharmaceutics. 2022 Nov 30;14(12):2659. doi: 10.3390/pharmaceutics14122659.